Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation in Latinamerica and EMEA Region (XANTUS-EL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01800006
Recruitment Status : Completed
First Posted : February 27, 2013
Last Update Posted : June 21, 2017
Janssen Research & Development, LLC
Information provided by (Responsible Party):

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : January 16, 2016
  Study Completion Date : June 20, 2016